Andrew M. Blakely, MD

Principal Investigator
National Cancer Institute, United States

Presentation(s):

• 36: Phosphoproteomic Mass Spectrometry Reveals A Novel Therapeutic Target in Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors

  Thursday, March 21, 2024
  10:57am – 11:07am ET

• 74: In Vivo Analysis of Protein Level Effects of Hyperthermic Intraperitoneal Chemotherapy

  Thursday, March 21, 2024
  2:52pm – 3:02pm ET

• 88: Spatially resolved transcriptomic analysis of hereditary diffuse gastric cancer reveals a unique phenotype of early-stage signet ring cell cancers

  Friday, March 22, 2024
  2:30pm – 2:42pm ET